Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rachel Y. Lei"'
Autor:
Charles E. Leonard, Yunfei Wang, Lina Asmar, Rachel Y. Lei, Kathryn T. Howell, Phyllis L. Henkenberns, Timothy K. Johnson, Tracy L. Hobart, Shannon P. Tole, Jane M. Kercher, Jodi L. Widner, Lora Barke, Terese Kaske, Dennis L. Carter
Publikováno v:
Cancer Medicine, Vol 10, Iss 20, Pp 7089-7100 (2021)
Abstract Purpose/Objective The primary objective is to examine patient self‐assessment of breast pain and cosmesis between three‐dimensional (3D‐CRT) versus intensity‐modulated radiotherapy (IMRT). The secondary objective is to evaluate any r
Externí odkaz:
https://doaj.org/article/df9360285429476a8a0b62eae7f1c431
Autor:
Rachel Y. Lei, MA, Dennis L. Carter, MD, Andrew G. Antell, MD, Molly A. Nowels, MA, MS, Shannon P. Tole, BA, John P. Bennett, MPH, Michelle Turner, MS, Frederick L. Baehner, MD, Charles E. Leonard, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100607- (2021)
Purpose: To compare ipsilateral breast event (IBE) risks in patients with ductal carcinoma in situ of the breast (DCIS) post-lumpectomy, as estimated by breast radiation oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer
Externí odkaz:
https://doaj.org/article/f94e000d9941493f918d76c85d826554
Publikováno v:
Cancer Research. 77:P1-11
Purpose: To compare ipsilateral breast event (IBE) risks in patients with DCIS of the breast post-lumpectomy, as estimated by breast radiation oncologists, the Van Nuys Prognostic Index (VNPI) studies, the Memorial Sloan Kettering Cancer Center (MSK)
Autor:
Tracy L. Hobart, Charles E. Leonard, Timothy K. Johnson, Shannon P. Fryman, Rachel Y. Lei, P. Henkenberns, Jane Kercher, Dennis L. Carter, Jodi L. Widner, Kathryn Howell, Terese Kaske
Publikováno v:
Breast Cancer Research and Treatment
This prospective Phase II single-arm study gathered data on the use of intensity-modulated radiotherapy (IMRT) to deliver accelerated partial breast irradiation (APBI). Four-year efficacy, cosmesis, and toxicity results are presented. Between Februar
Autor:
Michael, Alvarado, Dennis L, Carter, J Michael, Guenther, James, Hagans, Rachel Y, Lei, Charles E, Leonard, Jennifer, Manders, Amy P, Sing, Michael S, Broder, Dasha, Cherepanov, Eunice, Chang, Marianne, Eagan, Wendy, Hsiao, Michael J, Schultz
Publikováno v:
Journal of surgical oncology. 111(8)
Twenty percent of breast cancers are ductal carcinoma in situ (DCIS), with 15-60% having a local recurrence (LR) after surgery. Radiotherapy reduces LR by 50% but has not impacted survival. The validated Oncotype DX(®) 12-gene assay (DCIS Score) pro
Autor:
Dasha Cherepanov, James Hagans, JM Guenther, Michael Schultz, Michael Alvarado, Jennifer Manders, Charles E. Leonard, Michael S. Broder, Rachel Y. Lei, Wendy C. Hsiao, E. Chang, A.P. Sing, M. Eagan, Dennis L. Carter
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 90:S223-S224
Autor:
Molly Nowels, Charles E. Leonard, A.G. Antell, Rachel Y. Lei, S.P. Fryman, E. Janotta, Dennis L. Carter
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:E45
Quality Consortium (MROQC), a statewide assessment of breast cancer patients undergoing radiation therapy and crude rates were used for comparisons. Results: For left sided cancers, mean heart dose was 3.09 Gy. The use of a breast cup resulted in mea
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 93:E371
Autor:
Eunice Chang, James Hagans, Dasha Cherepanov, J. Michael Guenther, Jennifer Manders, Michael S. Broder, Michael Alvarado, Rachel Y. Lei, Charles E. Leonard, Amy P. Sing, Wendy C. Hsiao, Michael Schultz, Dennis L. Carter
Publikováno v:
Journal of Clinical Oncology. 32:11050-11050
11050 Background: About 20% of breast cancers (BC) are DCIS. Local recurrence (LR) rates with surgery alone are 15-60%; about 50% are invasive. Radiation (XRT) reduces LR by 50% but has not impacte...
Autor:
Charles E. Leonard, P. Henkenberns, Lora Barke, R.M. LaPorte, S.P. Fryman, Jodi L. Widner, Rachel Y. Lei, Dennis L. Carter, R.D. Higdon, K. Howell
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 87:S196
RTOG/EORTC Late Radiation Morbidity systems were used for evaluation of skin, subcutaneous and non-cutaneous toxicities. Median follow-up was 82.5 months (range, 2-104 months). Results: At 4 years, the physician rating of overall cosmesis was good or